Nucleotide salvage deficiencies, DNA damage and neurodegeneration

International Journal of Molecular Sciences

Volumn 16, Issue 5, 2015, Pages 9431-9449

  Fasullo, Michael ^a   Endres, Lauren ^a  

^a SUNY POLYTECHNIC INSTITUTE   (United States)

Author keywords

Genetic stability; Mitochondrial DNA stability; Neurodegenerative diseases; Nucleotide salvage

Indexed keywords

ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ATM PROTEIN; DEOXYGUANOSINE DIPHOSPHATE; DEOXYGUANOSINE KINASE; DEOXYGUANOSINE PHOSPHATE; DEOXYGUANOSINE TRIPHOSPHATE; DEOXYRIBONUCLEOTIDE; GUANINE NUCLEOTIDE; GUANOSINE PHOSPHATE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INOSINE; MITOCHONDRIAL DNA; PHOSPHORIBOSYL PYROPHOSPHATE; PROTEIN P53; RIBONUCLEOTIDE REDUCTASE; THYMIDINE DIPHOSPHATE; THYMIDINE KINASE 2; THYMIDINE PHOSPHATE; THYMIDINE PHOSPHORYLASE; THYMIDINE TRIPHOSPHATE; UNCLASSIFIED DRUG; URIC ACID; URIDINE PHOSPHORYLASE; NUCLEOTIDE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ATAXIA TELANGIECTASIA; BIOCHEMISTRY; DNA DAMAGE; GENE MUTATION; GENE OVEREXPRESSION; GENETIC DISORDER; GENETIC STABILITY; HUMAN; LESCH NYHAN SYNDROME; MITOCHONDRIAL DNA DEPLETION SYNDROME; MNGIE SYNDROME; NERVE DEGENERATION; NONHUMAN; NUCLEOTIDE METABOLISM; NUCLEOTIDE SALVAGE DEFICIENCY; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA REPAIR; DNA REPLICATION; GENETICS; METABOLISM; MITOCHONDRION; MOUSE; TRANSGENIC MOUSE;

ANIMALIA;

ADENOSINE TRIPHOSPHATE; ANIMALS; ATAXIA TELANGIECTASIA; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA, MITOCHONDRIAL; GENETIC DISEASES, INBORN; HUMANS; LESCH-NYHAN SYNDROME; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MITOCHONDRIAL DISEASES; NEURODEGENERATIVE DISEASES; NUCLEOTIDES; OXIDATIVE STRESS; PURINES; PYRIMIDINES; SIGNAL TRANSDUCTION;

EID: 84929353036     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16059431     Document Type: Review

References (84)

1. Micheli, V.; Camici, M.; Tozzi, M.G.; Ipata, P.L.; Sestini, S.; Bertelli, M.; Pompucci, G. Neurological disorders of purine and pyrimidine metabolism. Curr. Top. Med. Chem. 2011, 11, 923–947.
2. Chabes, A.; Bilyana, G.; Domkin, V.; Zhao, X.; Rothstein, R.; Thelander, L. Survival of DNA damage in yeast directly depends on increased dNTP levels allowed by relaxed feedback inhibition of ribonucleotide reductase. Cell 2003, 112, 391–401.
3. Fasullo, M.; Koudelik, J.; AhChing, P.; Giallanza, P.; Cera, C. Radiosensitive and mitotic recombination phenotypes of the Saccharomyces cerevisiae dun1 mutant defective in DNA damage-inducible gene expression. Genetics 1999, 152, 909–919.
4. Fikus, M.U.; Mieczkowski, P.A.; Koprowski, P.; Rytka, J.; Sledziewska-Gójska, E.; Ciésla, Z. The product of the DNA damage-inducible gene of Saccharomyces cerevisiae, DIN7, specifically functions in mitochondria. Genetics 2000, 154, 73–81.
5. Weinberg, G.; Ullman, B.; Martin, D.W. Mutator phenotypes in mammalian cell mutants with distinct biochemical defects and abnormal deoxyribonucleoside triphosphate pools. Proc. Natl. Acad. Sci. USA 1981, 78, 2447–2451.
6. Fu, R.; Ceballos-Picot, I.; Torres, R.J.; Larovere, L.E.; Yamada, Y.; Nguyen, K.V.; Hegde, M.; Visser, J.E.; Schretlen, D.J.; Nyhan, W.L., et al. Lesch-Nyhan Disease International Study Group. Brain. Genotype–phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. Brain 2014, 137, 1282–1303.
7. Nogueira, C.; Almeida, L.S.; Nesti, C.; Pezzini, I.; Videira, A.; Vilarinho, L.; Santorelli, F.M. Syndromes associated with mitochondrial DNA depletion. Ital. J. Pediatr. 2014, 40, 34.
8. Copeland, W.C.; Longley, M.J. Mitochondrial genome maintenance in health and disease. DNA Repair 2014, 19, 190–198.
9. Nishino, I.; Spinazzola, A.; Hirano, M. Thymidine phosphorylase gene mutations in MNGIE, a Human Mitochondrial Disorder. Science 1999, 283, 689–692.
10. Bunimovich, Y.L.; Nair-Gill, E.; Riedinger, M.; McCracken, M.N.; Cheng, D.; McLaughlin, J.; Radu, C.G.; Witte, O.N. Deoxycytidine kinase augments ATM-mediated DNA repair and contributes to radiation resistance. PLoS ONE 2014, 9, e104125.
11. Sharma, N.K.; Lebedeva, M.; Thomas, T.; Kovalenko, O.A.; Stumpf, J.D.; Shadel, G.S.; Santos, J.H. Intrinsic mitochondrial DNA repair defects in Ataxia Telangiectasia. DNA Repair 2014, 13, 22–31.
12. Ambrose, M.; Gatti, R.A. Pathogenesis of ataxia-telangiectasia: The next generation of ATM functions. Blood 2013, 121, 4036–4045.
13. Pollard, J.M.; Gatti, R.A. Clinical radiation sensitivity with DNA repair disorders: An overview. Int. J. Radiat. Oncol. Biol. Phys. 2009, 74, 1323–1331.
14. Federico, A.; Cardaioli, E.; da Pozzo, P.; Formichi, P.; Gallus, G.N.; Radi, E. Mitochondria, oxidative stress and neurodegeneration. J. Neurol. Sci. 2012, 322, 254–262.
15. Bélanger, M.; Allaman, I.; Magistretti, P.J. Brain energy metabolism: Focus on astrocyte-neuron metabolic cooperation. Cell Metab. 2011, 14, 724–738.
16. Furda, A.M.; Marrangoni, A.M.; Lokshin, A.; van Houten, B. Oxidants and not alkylating agents induce rapid mtDNA loss and mitochondrial dysfunction. DNA Repair 2012, 11, 684–692.
17. Scheibye-Knudsen, M.; Fang E.F., Croteau, D.L.; Wilson, D.M., 3rd; Bohr, V.A. Protecting the mitochondrial powerhouse. Trends Cell Biol. 2014, 25, 158–170.
18. Pursell, Z.F.; McDonald, J.T.; Mathews, C.K.; Kunkel, T.A. Trace amounts of 8-oxo-dGTP in mitochondrial dNTP pools reduce DNA polymerase gamma replication fidelity. Nucleic Acids Res. 2008, 36, 2174–2181.
19. Desler, C.; Lykke, A.; Rasmussen, L.J. The effect of mitochondrial dysfunction on cytosolic nucleotide metabolism. J. Nucleic Acids 2010, 2010, 701518.
20. Pontarin, G.; Ferraro, P.; Bee, L.; Reichard, P.; Bianchi, V. Mammalian ribonucleotide reductase subunit p53R2 is required for mitochondrial DNA replication and DNA repair in quiescent cells. Proc. Natl. Acad. Sci. USA 2012, 109, 13302–13307.
21. Nordlund, P.; Reichard, P. Ribonucleotide reductases. Annu. Rev. Biochem. 2006, 75, 681–706.
22. Abbracchio, M.P.; Burnstock, G.; Verkhratsky, A.; Zimmermann, H. Purinergic signalling in the nervous system: An overview. Trends Neurosci. 2009, 32, 19–29.
23. Averaimo, S.; Nicol, X. Intermingled cAMP, cGMP and calcium spatiotemporal dynamics in developing neuronal circuits. Front. Cell. Neurosci. 2014, 8, 376.
24. Deutsch, S.I.; Long, K.D.; Rosse, R.B.; Mastropaolo, J.; Eller, J. Hypothesized deficiency of guanine-based purines may contribute to abnormalities of neurodevelopment, neuromodulation, and neurotransmission in Lesch-Nyhan syndrome. Clin. Neuropharmacol. 2005, 28, 28–37.
25. Nelson, D.L.; Lehninger, A.L.; Cox, M.M. Lehninger Principles of Biochemistry, 5th ed.; Ch WH Freeman and Company: New York, NY, USA, 2008; pp. 882–900.
26. Ceballos-Picot, I.; Mockel, L.; Potier, M.C.; Dauphinot, L.; Shirley T.L.; Torero-Ibad, R.; Fuchs, J.; Jinnah, H.A. Hypoxanthine-guanine phosphoribosyl transferase regulates early developmental programming of dopamine neurons: Implications for Lesch-Nyhan disease pathogenesis. Hum. Mol. Genet. 2009, 18, 2317–2327.
27. Rampazzo, C.; Miazzi, C.; Franzolin, E.; Pontarin, G.; Ferraro, P.; Frangini, M.; Reichard, P.; Bianchi V. Regulation by degradation, a cellular defense against deoxyribonucleotide pool imbalances. Mutat. Res. 2010, 703, 2–10.
28. Battelli, M.G.; Bolognesi, A.; Polito, L. Pathophysiology of circulating xanthine oxidoreductase: New emerging roles for a multi-tasking enzyme. Biochim. Biophys. Acta 2014, 1842, 1502–1517.
29. Steiger, S.; Harper, J.L. Mechanisms of spontaneous resolution of acute gouty inflammation. Curr. Rheumatol. Rep. 2014, 16, 392.
30. Wheeler, L.J.; Mathews, C.K. Nucleoside triphosphate pool asymmetry in mammalian mitochondria. J. Biol. Chem. 2011, 286, 16992–16996.
31. Saada, A. Mitochondrial deoxyribonucleotide pools in deoxyguanosine kinase deficiency. Mol. Genet. Metab. 2008, 95, 169–173.
32. Ferraro, P.; Nicolosi, L.; Bernardi, P.; Reichard, P.; Bianchi, V. Mitochondrial deoxynucleotide pool sizes in mouse liver and evidence for a transport mechanism for thymidine monophosphate. Proc. Natl. Acad. Sci. USA 2006, 103, 18586–18991.
33. Martí, R.; Dorado, B.; Hirano, M. Measurement of mitochondrial dNTP pools. Methods Mol. Biol. 2012, 837, 135–148.
34. Jinnah, H.A.; Ceballos-Picot, I.; Torres, R.J.; Visser, J.E.; Schretlen, D.J.; Verdu, A.; Laróvere, L.E.; Chen, C.J.; Cossu, A.; Wu, C.H., et al. Lesch-Nyhan Disease International Study Group. Attenuated variants of Lesch-Nyhan disease. Brain 2010, 133 Pt 3, 671–689.
35. Mizunuma, M.; Fujimori, S.; Ogino, H.; Ueno, T.; Inoue, H.; Kamatani, N. A recurrent large Alu-mediated deletion in the hypoxanthine phosphoribosyltransferase (HPRT1) gene associated with Lesch-Nyhan syndrome. Hum. Mutat. 2001, 18, 435–443.
36. Sampat, R.; Fu, R.; Larovere, L.E.; Torres, R.J.; Ceballos-Picot, I.; Fischbach, M.; de Kremer R.; Schretlen, D.J.; Puig, J.G.; Jinnah, H.A. Mechanisms for phenotypic variation in Lesch-Nyhan disease and its variants. Hum. Genet. 2011, 129, 71–78.
37. Camici, M.; Micheli, V.; Ipata, P.L.; Tozzi, M.G. Pediatric neurological syndromes and inborn errors of purine metabolism. Neurochem. Int. 2010, 56, 367–378.
38. Ernst, M.; Zametkin, A.J.; Matochik, J.A.; Pascualvaca, D.; Jons, P.H.; Hardy, K.; Hankerson, J.G.; Doudet, D.J.; Cohen, R.M. Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N. Engl. J. Med. 1996, 334, 1568–1572.
39. Wong, D.F.; Harris, J.C.; Naidu, S.; Yokoi, F.; Marenco, S.; Ravert, H.T.; Yaster, M.; Evans, A.; Rousset, O.; Bryan, R.N., et al. Dopamine transporter are markedly reduced in Lesch-Nyhan disease in vivo. Proc. Natl. Acad. Sci. USA 1996, 93, 5539–5543.
40. White, W.F.; Dichter, M.A.; Snodgrass, R. Benzodiazepine binding and interactions with the GABA receptor complex in living cultures of rat cerebral cortex. Brain Res. 1981, 215, 162–176.
41. Göttle, M.; Prudente, C.N.; Fu, R.; Sutcliffe, D.; Pang, H.; Cooper, D.; Veledar, E.; Glass, J.D.; Gearing, M.; Visser, J.E., et al. Loss of dopamine phenotype among midbrain neurons in Lesch-Nyhan disease. Ann. Neurol. 2014, 76, 95–107.
42. Fairbanks, L.D.; Jacomelli, G.; Micheli, V.; Slade, T.; Simmonds, H.A. Severe pyridine nucleotide depletion in fibroblasts from Lesch-Nyhan patients. J. Neurochem. 1999, 72, 1139–1145.
43. McCreanor, G.M.; Harkness, R.A. Lesch-Nyhan syndrome and its pathogenesis: Normal nicotinamide-adenine dinucleotide but reduced ATP concentrations that correlate with reduced poly(ADP-ribose) synthetase activity in HPRT-deficient lymphoblasts. J. Inherit. Metab. Dis. 1995, 18, 737–747.
44. Kang, T.H.; Park, Y.; Bader, J.S.; Friedmann, T. The housekeeping gene hypoxanthine guanine phosphoribosyltransferase (HPRT) regulates multiple developmental and metabolic pathways of murine embryonic stem cell neuronal differentiation. PLoS ONE 2013, 8, e74967.
45. Mastrangelo, L.; Kim, J.E.; Miyanohara, A.; Kang, T.H.; Friedmann, T. Purinergic signaling in human pluripotent stem cells is regulated by the housekeeping gene encoding hypoxanthine guanine phosphoribosyltransferase. Proc. Natl. Acad. Sci. USA 2012, 109, 3377–3382.
46. Guibinga, G.H.; Murray, F.; Barron, N. HPRT-deficiency dysregulates cAMP-PKA signaling and phosphodiesterase 10A expression: Mechanistic insight and potential target for Lesch-Nyhan Disease? PLoS ONE 2013, 18, e63333.
47. Watts, R.W.; Harkness, R.A.; Spellacy, E.; Taylor, N.F. Lesch-Nyhan syndrome: Growth delay, testicular atrophy and a partial failure of the 11β-hydroxylation of steroids. J. Inherit. Metab. Dis. 1987, 10, 210–223.
48. Copeland, W.C. Defects in mitochondrial DNA replication and human disease. Crit. Rev. Biochem. Mol. Biol. 2012, 47, 64–74.
49. Tyynismaa, H.; Suomalainen, A. Mouse models of mitochondrial DNA defects and their relevance for human disease. EMBO Rep. 2009, 10, 137–143.
50. Mandel, H.; Szargel, R.; Labay, V.; Elpeleg, O.; Saada, A.; Shalata, A.; Anbinder, Y.; Berkowitz, D.; Hartman, C.; Barak, M., et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat. Genet. 2001, 29, 337–341.
51. Johansson, M.; Karlsson, A. Cloning and expression of human deoxyguanosine kinase cDNA. Proc. Natl. Acad. Sci. USA 1996, 93, 7258–7262.
52. Eriksson, S.; Wang, L. Molecular mechanisms of mitochondrial DNA depletion diseases caused by deficiencies in enzymes in purine and pyrimidine metabolism. Nucleosides Nucleotides Nucleic Acids 2008, 27, 800–808.
53. Dimmock, D.P.; Zhang, Q.; Dionisi-Vici, C.; Carrozzo, R.; Shieh, J.; Tang, L.-Y.; Truong, C.; Schmitt, E.; Sifry-Platt, M.; Lucioli, S., et al. Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum. Mutat. 2008, 29, 330–331.
54. Freisinger, P.; Fütterer, N.; Lankes, E.; Gempel, K.; Berger, T.M.; Spalinger, J.; Hoerbe, A.; Schwantes, C.; Lindner, M.; Santer, R., et al. Hepatocerebral mitochondrial DNA depletion syndrome caused by deoxyguanosine kinase (DGUOK) mutations. Arch. Neurol. 2006, 63, 1129–1134.
55. Buchaklian, A.H.; Helbling, D.; Ware, S.M.; Dimmock, D.P. Recessive deoxyguanosine kinase deficiency causes juvenile onset mitochondrial myopathy. Mol. Genet. Metab. 2012, 107, 92–94.
56. Tyynismaa, H.; Sun, R.; Ahola-Erkkilä, S.; Almusa, H.; Pöyhönen, R.; Korpela, M.; Honkaniemi, J.; Isohanni, P.; Paetau, A.; Wang, L., et al. Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Hum. Mol. Genet. 2012, 21, 66–75.
57. Kalko, S.G.; Paco, S.; Jou, C.; Rodríguez, M.A.; Meznaric, M.; Rogac, M.; Jekovec-Vrhovsek, M.; Sciacco, M.; Moggio, M.; Fagiolari, G., et al. Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies. BMC Genomics 2014, 15, 91.
58. Giordano, C.; Sebastiani, M.; de Giorgio, R.; Travaglini, C.; Tancredi, A.; Valentino, M.L.; Bellan, M.; Cossarizza, A.; Hirano, M.; d’Amati, G., et al. Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion. Am. J. Pathol. 2008, 173, 1120–1128.
59. Libernini, L.; Lupis, C.; Mastrangelo, M.; Carrozzo, R.; Santorelli, F.M.; Inghilleri, M.; Leuzzi, V. Mitochondrial neurogastrointestinal encephalomyopathy: Novel pathogenic mutations in thymidine phosphorylase gene in two Italian brothers. Neuropediatrics 2012, 43, 201–208.
60. Valentino, M.L.; Martí, R.; Tadesse, S.; López, L.C.; Manes, J.L.; Lyzak, J.; Hahn, A.; Carelli, V.; Hirano, M. Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). FEBS. Lett. 2007, 581, 3410–3414.
61. González-Vioque, E.; Torres-Torronteras, J.; Andreu, A.L.; Martí, R. Limited dCTP availability accounts for mitochondrial DNA depletion in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). PLoS Genet. 2011, 7, e1002035.
62. Filosto, M.; Scarpelli, M.; Tonin, P.; Lucchini, G.; Pavan, F.; Santus, F.; Parini, R.; Donati, M.A.; Cotelli, M.S.; Vielmi, V., et al. Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy. J. Neurol. 2012, 259, 2699–2706.
63. Tyynismaa, H.; Carroll, C.J.; Raimundo, N.; Ahola-Erkkilä, S.; Wenz, T.; Ruhanen, H.; Guse, K.; Hemminki, A.; Peltola-Mjøsund, K.E.; Tulkki, V., et al. Mitochondrial myopathy induces a starvation-like response. Hum. Mol. Genet. 2010, 19, 3948–3958.
64. Bourdon, A.; Minai, L.; Serre, V.; Jais, J.P.; Sarzi, E.; Aubert, S.; Chrétien, D.; de Lonlay, P.; Paquis-Flucklinger, V.; Arakawa, H., et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat. Genet. 2007, 39, 776–780.
65. Pontarin, G.; Ferraro, P.; Rampazzo, C.; Kollberg, G.; Holme, E.; Reichard, P.; Bianchi, V. Deoxyribonucleotide metabolism in cycling and resting human fibroblasts with a missense mutation in p53R2, a subunit of ribonucleotide reductase. J. Biol. Chem. 2011, 286, 11132–11140.
66. Tyynismaa, H.; Ylikallio, E.; Patel, M.; Molnar, M.J.; Haller, R.G.; Suomalainen, A. A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions. Am. J. Hum. Genet. 2009, 85, 290–295.
67. Eaton, J.S.; Lin, Z.P.; Sartorelli, A.C.; Bonawitz, N.D.; Shadel, G.S. Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis. J. Clin. Investig. 2007, 117, 2723–2734.
68. Hooper, M.; Hardy, K.; Handyside, A.; Hunter, S.; Monk, M. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 1987, 326, 292–295.
69. Jinnah, H.A.; Page, T.; Friedmann, T. Brain purines in a genetic mouse model of Lesch-Nyhan disease. J. Neurochem. 1993, 60, 2036–2045.
70. Visser, J.E.; Smith, D.W.; Moy, S.S.; Breese, G.R.; Friedmann, T.; Rothstein, J.D; Jinnah, H.A. Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. Brain Res. Dev. Brain Res. 2002, 133, 127–139.
71. Pelled, D.; Sperling, O.; Zoref-Shani, E. Abnormal purine and pyrimidine nucleotide content in primary astroglia cultures from hypoxanthine-guanine phosphoribosyltransferase-deficient transgenic mice. J. Neurochem. 1999, 72, 1139–1145.
72. Jinnah, H.A.; de Gregorio, L.; Harris, J.C.; Nyhan, W.L.; O’Neill, J.P. The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. Mutat. Res. 2000, 463, 309–326.
73. Zhou, X.; Solaroli, N.; Bjerke, M.; Stewart, J.B.; Rozell, B.; Johansson, M.; Karlsson, A. Progressive loss of mitochondrial DNA in thymidine kinase 2-deficient mice. Hum. Mol. Genet. 2008, 17, 2329–2335.
74. Akman, H.O.; Dorado, B.; López, L.C.; García-Cazorla, A.; Vilà, M.R.; Tanabe, L.M.; Dauer, W.T.; Bonilla, E.; Tanji, K.; Hirano, M. Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance. Hum. Mol. Genet. 2008, 17, 2433–2440.
75. Krishnan, S.; Paredes, J.A; Zhou, X.; Kuiper, R.V.; Curbo, S.; Karlsson, A. Long term expression of Drosophila melanogaster nucleoside kinase in thymidine kinase 2-deficient mice with no lethal effects caused by nucleotide pool imbalances. J. Biol. Chem. 2014, 288, 32835–32844
76. Lopez, L.C.; Akman, H.O.; García-Cazorla, A.; Dorado, B.; Martí, R.; Nishino, I.; Tadesse, S.; Pizzorno, G.; Shungu, D.; Bonilla, E., et al. Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice. Hum. Mol. Genet. 2009, 18, 714–722.
77. Kimura, T.; Takeda, S.; Sagiya, Y.; Gotoh, M.; Nakamura, Y.; Arakawa, H. Impaired function of p53R2 in Rrm2b-null mice causes severe renal failure through attenuation of dNTP pools. Nat. Genet. 2003, 34, 440–445.
78. Ylikallio, E.; Page, J.L.; Xu, X.; Lampinen, M.; Bepler, G.; Ide, T.; Tyynismaa, H.; Weiss, R.S.; Suomalainen, A. Ribonucleotide reductase is not limiting for mitochondrial DNA copy number in mice. Nucleic Acids Res. 2010, 38, 8208–8218.
79. Stern, N.; Hochman, A.; Zemach, N.; Weizman, N.; Hammel, I.; Shiloh, Y.; Rotman, G.; Barzilai, A. Accumulation of DNA damage and reduced levels of nicotine adenine dinucleotide in the brains of Atm-deficient mice. J. Biol. Chem. 2002, 277, 602–608.
80. Lavin, M.F. The appropriateness of the mouse model for ataxia-telangiectasia: Neurological defects but no neurodegeneration. DNA Repair 2013, 12, 612–619.
81. Fasullo, M.; Tsaponina, O; Sun, M.; Chabes, A. Elevated dNTP levels suppress hyper-recombination in Saccharomyces cerevisiae S-phase checkpoint mutants. Nucleic Acids Res. 2010, 38, 1195–1203.
82. Taylor, S.D.; Zhang, H.; Eaton, J.S.; Rodeheffer, M.S.; Lebedeva, M.A.; O’Rourke T.W.; Siede, W.; Shadel, G.S. The conserved Mec1/Rad53 nuclear checkpoint pathway regulates mitochondrial DNA copy number in Saccharomyces cerevisiae. Mol. Biol. Cell 2005, 16, 3010–3018.
83. Glick, N. Dramatic reduction in self-injury in Lesch-Nyhan disease following S-adenosylmethionine administration. J. Inherit. Metab. Dis. 2006, 29, 687.
84. El-Hattab, A.E.; Scaglia, F. Mitochondrial DNA depletion syndromes: Review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics 2013, 10, 186–198.